20 employees
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients.
2020
$80M
from 6 investors over 6 rounds
NextPoint Therapeutics, Inc. raised $80M on January 10, 2023
Investors: Sanofi Ventures, Catalio Capital Management, Sixty Degree Capital, Leaps by Bayer, MPM Capital and The Invus Group